IDIOPATHIC VENTRICULAR-TACHYCARDIA AND FIBRILLATION

被引:129
作者
BELHASSEN, B
VISKIN, S
机构
[1] Department of Cardiology, Tel Aviv-Elias Sourasky Medical Center, Tel-Aviv
[2] Sackler School of Medicine, Tel-Aviv University, Tel-Aviv
关键词
VENTRICULAR TACHYCARDIA; VENTRICULAR FIBRILLATION; TORSADE-DE-POINTES; SUDDEN CARDIAC DEATH;
D O I
10.1111/j.1540-8167.1993.tb01236.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Important data have recently been added to our understanding of sustained ventricular tachyarrhythmias occurring in the absence of demonstrable heart disease. Idiopathic ventricular tachycardia (VT) is usually of monomorphic configuration and can be classified according to its site of origin as either right monomorphic (70% of all idiopathic VTs) or left monomorphic VT. Several physiopathological types of monomorphic VT can be presently individualized, according to their mode of presentation, their relationship to adrenergic stress, or their response to various drugs. The long-term prognosis is usually good. Idiopathic polymorphic VT is a much rarer type of arrhythmia with a less favorable prognosis. Idiopathic ventricular fibrillation may represent an underestimated cause of sudden cardiac death in ostensibly healthy patients. A high incidence of inducibility of sustained polymorphic VT with programmed ventricular stimulation has been found by our group, but not by others. Long-term prognosis on Class IA antiarrhythmic medications that are highly effective at electrophysiologic study appears excellent.
引用
收藏
页码:356 / 368
页数:13
相关论文
共 118 条
  • [91] Strasberg B, Welch W, Palileo E, Et al., Familial inducible torsade de pointes with normal QT interval, Eur Heart J, 4, pp. 383-390, (1983)
  • [92] Kontny F, Dale J, Self‐terminating idiopathic ventricular fibrillation presenting as syncope: A 40‐year follow‐up report, J Intern Med, 227, pp. 211-213, (1990)
  • [93] Wellens HJJ, Lemery R, Smeets JL, Et al., Sudden arrhythmic death without overt heart disease, Circulation, 85, pp. 92-97, (1992)
  • [94] Dock W, Transitory ventricular fibrillation as a cause of syncope and its prevention by quinidine sulfate, Am Heart J, 4, pp. 709-714, (1929)
  • [95] Belhassen B, Shapira I, Shoshani D, Et al., Idiopathic ventricular fibrillation: Inducibility and beneficial effects of class I antiarrhythmic agents, Circulation, 75, pp. 809-816, (1987)
  • [96] Meissner MD, Mosteller MD, Steinman RT, Et al., Cardiac arrest in patients without significant structural heart disease: A multicenter experience with implantable cardioverter‐defibrillator therapy, Journal of the American College of Cardiology, 17, (1991)
  • [97] Wever E, Hauer R, Oomen A, Et al., Unfavorable outcome in patients with primary electrical disease who survived unexpected cardiac arrest, Eur Heart J, 12, (1991)
  • [98] Siebels J, Schneider MAE, Geiger M, Et al., Unexpected recurrences in survivors of cardiac arrest without organic heart disease, Eur Heart J, 12, (1991)
  • [99] Roelke M, Powell AC, Liberthson RR, Et al., Electrophysiologic observations and long‐term follow‐up in eleven patients with idiopathic ventricular fibrillation, J Am Coll Cardiol, 19, (1992)
  • [100] Aizawa Y, Tamura M, Chinushi M, Et al., An attempt at electrical catheter ablation of the arrhythmogenic area in idiopathic ventricular fibrillation, Am Heart J, 123, pp. 257-260, (1992)